COVID-19 in Patients With Chronic Liver Diseases

Not Recruiting

Trial ID: NCT04439084

Age - 18 Years-N/A Gender - All Accepting Healthy Volunteers - No

Purpose

This study seeks to determine how COVID-19 affects the clinical outcome of patients with chronic liver disease, and whether the clinical course of COVID-19 is influenced by underlying chronic liver disease.

Official Title

COVID-19 in Patients With Chronic Liver Diseases

Stanford Investigator(s)

Renumathy Dhanasekaran
Renumathy Dhanasekaran

Assistant Professor of Medicine (Gastroenterology)

Eligibility


Inclusion Criteria:

   - Confirmed diagnosis of COVID-19

   - Personal history of either

      - Chronic hepatitis C

      - Chronic hepatitis B

      - Alcoholic liver disease

      - Non alcoholic liver disease

      - Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis

      - Cryptogenic cirrhosis

      - Hepatocellular carcinoma

Exclusion Criteria:

   - Non-COVID-19 patient

View More
View Less

Intervention(s):

other: Prospective Chart Review

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2022 Stanford Medicine